Complement Inhibitor [EPC]

Complement Inhibitor [EPC] was reported 56259 times

Drugs of the Complement Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 BREAKTHROUGH HAEMOLYSIS 350 0.8772
1 TOTAL COMPLEMENT ACTIVITY DECREASED 53 0.8689
2 EXTRAVASCULAR HAEMOLYSIS 347 0.8165
3 TOTAL COMPLEMENT ACTIVITY INCREASED 42 0.7925
4 HAEMOGLOBINURIA 740 0.6601
5 HAPTOGLOBIN ABNORMAL 52 0.5652
6 MENINGOCOCCAL SEPSIS 105 0.5526
7 MENINGOCOCCAL BACTERAEMIA 52 0.5417
8 COMPLEMENT FACTOR ABNORMAL 54 0.5047
9 PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA 228 0.4861
10 MENINGITIS MENINGOCOCCAL 77 0.4529
11 MENINGOCOCCAL INFECTION 125 0.3956
12 COMPLEMENT FACTOR INCREASED 33 0.3929
13 GONOCOCCAL INFECTION 26 0.3768
14 RETICULOCYTE COUNT INCREASED 278 0.3436
15 HAPTOGLOBIN DECREASED 272 0.3375
16 RETICULOCYTE COUNT ABNORMAL 33 0.2946
17 HAEMOLYSIS 2233 0.2889
18 BIOPSY BONE MARROW 131 0.2799
19 BLOOD LACTATE DEHYDROGENASE ABNORMAL 189 0.2788
20 C3 GLOMERULOPATHY 56 0.2705
21 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 217 0.2669
22 PLASMAPHERESIS 135 0.2586
23 NEISSERIA INFECTION 31 0.2441
24 BLOOD PRODUCT TRANSFUSION DEPENDENT 101 0.2399
25 HAPTOGLOBIN INCREASED 32 0.2336
26 MYASTHENIA GRAVIS CRISIS 323 0.2178
27 BUDD-CHIARI SYNDROME 52 0.2055
28 BLOOD LACTATE DEHYDROGENASE DECREASED 66 0.1982
29 ARTERIOVENOUS FISTULA OCCLUSION 34 0.1943
30 INTRAVASCULAR HAEMOLYSIS 104 0.1857
31 IRON OVERLOAD 181 0.1676
32 COMPLEMENT FACTOR C3 DECREASED 37 0.1516
33 NEUROMYELITIS OPTICA SPECTRUM DISORDER 197 0.1460
34 COMPLEMENT FACTOR DECREASED 25 0.1397
35 RETINAL OCCLUSIVE VASCULITIS 31 0.1384
36 IRON BINDING CAPACITY TOTAL DECREASED 30 0.1357
37 PACKED RED BLOOD CELL TRANSFUSION 169 0.1276
38 MYASTHENIA GRAVIS 1016 0.1257
39 RED BLOOD CELL SCHISTOCYTES PRESENT 40 0.1235
40 RETICULOCYTOSIS 25 0.1179
41 INTRA-OCULAR INJECTION COMPLICATION 25 0.1101
42 BLOOD LACTATE DEHYDROGENASE INCREASED 1744 0.1100
43 EYE COMPLICATION ASSOCIATED WITH DEVICE 29 0.1078
44 HEPATIC VEIN THROMBOSIS 34 0.1076
45 COOMBS TEST POSITIVE 29 0.1062
46 APLASTIC ANAEMIA 548 0.1048
47 HAEMATOCRIT ABNORMAL 117 0.0951
48 HAEMOLYTIC URAEMIC SYNDROME 207 0.0892
49 THROMBOTIC MICROANGIOPATHY 860 0.0882
50 BIOPSY KIDNEY 25 0.0877
51 RENAL TRANSPLANT FAILURE 84 0.0850
52 HAEMOGLOBIN ABNORMAL 547 0.0850
53 PLATELET TRANSFUSION 103 0.0800
54 CHOROIDAL NEOVASCULARISATION 65 0.0758
55 BLOOD IRON INCREASED 142 0.0756
56 EXPOSURE VIA BODY FLUID 58 0.0738
57 BONE MARROW TRANSPLANT 138 0.0727
58 RETICULOCYTE COUNT DECREASED 31 0.0719
59 SUSPECTED COVID-19 235 0.0712
60 TRANSFUSION 742 0.0707
61 BLOOD CREATININE ABNORMAL 242 0.0699
62 POOR VENOUS ACCESS 709 0.0684
63 VACCINATION SITE PAIN 36 0.0626
64 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 32 0.0611
65 BLOOD UREA ABNORMAL 57 0.0606
66 SYMPTOM RECURRENCE 360 0.0601
67 GRAFT LOSS 40 0.0552
68 RENAL TRANSPLANT 196 0.0542
69 MEAN CELL HAEMOGLOBIN INCREASED 89 0.0537
70 MEAN CELL VOLUME INCREASED 136 0.0529
71 MASTICATION DISORDER 160 0.0522
72 EYELID PTOSIS 511 0.0502
73 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 39 0.0495
74 NEOVASCULAR AGE-RELATED MACULAR DEGENERATION 68 0.0486
75 MEAN PLATELET VOLUME DECREASED 40 0.0477
76 PLATELET COUNT ABNORMAL 288 0.0476
77 RETINAL VASCULITIS 56 0.0470
78 ARTERIOVENOUS FISTULA SITE COMPLICATION 28 0.0467
79 RED BLOOD CELL COUNT ABNORMAL 68 0.0463
80 CENTRAL VENOUS CATHETERISATION 138 0.0457
81 TRANSFUSION REACTION 40 0.0456
82 MALIGNANT HYPERTENSION 39 0.0454
83 CHROMATURIA 989 0.0438
84 HAEMOGLOBIN DECREASED 4403 0.0428
85 VITRITIS 75 0.0405
86 MULTIMORBIDITY 48 0.0401
87 CRITICAL ILLNESS 30 0.0385
88 GENE MUTATION 74 0.0374
89 ANTIBODY TEST ABNORMAL 26 0.0361
90 EPSTEIN-BARR VIRAEMIA 39 0.0352
91 BLOOD BILIRUBIN ABNORMAL 45 0.0351
92 SERUM FERRITIN INCREASED 182 0.0345
93 VEIN COLLAPSE 26 0.0339
94 QUALITY OF LIFE DECREASED 448 0.0334
95 POLYOMAVIRUS VIRAEMIA 35 0.0330
96 OESOPHAGEAL SPASM 60 0.0325
97 HAEMOCHROMATOSIS 29 0.0314
98 HAEMATOCRIT DECREASED 613 0.0309
99 RED CELL DISTRIBUTION WIDTH INCREASED 126 0.0303
100 MENINGITIS 202 0.0302
101 CANDIDA SEPSIS 26 0.0290
102 KIDNEY FIBROSIS 50 0.0288
103 MICROANGIOPATHY 26 0.0277
104 BLOOD ALKALINE PHOSPHATASE DECREASED 26 0.0274
105 CATHETER PLACEMENT 50 0.0269
106 DRY AGE-RELATED MACULAR DEGENERATION 29 0.0261
107 BONE MARROW DISORDER 78 0.0258
108 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 43 0.0258
109 DIPLOPIA 639 0.0246
110 KIDNEY TRANSPLANT REJECTION 118 0.0246
111 TRANSPLANT FAILURE 59 0.0240
112 OCULAR ICTERUS 104 0.0240
113 ESCHERICHIA TEST POSITIVE 28 0.0234
114 TRANSPLANT 55 0.0231
115 TRANSPLANT REJECTION 184 0.0229
116 MYELODYSPLASTIC SYNDROME 331 0.0229
117 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 53 0.0226
118 ANTIPHOSPHOLIPID SYNDROME 36 0.0224
119 CATHETER SITE PAIN 58 0.0223
120 CARBON DIOXIDE DECREASED 25 0.0217
121 DEVICE RELATED INFECTION 334 0.0217
122 MONOCYTE COUNT DECREASED 25 0.0205
123 GLOMERULAR FILTRATION RATE ABNORMAL 29 0.0205
124 PLATELET DISORDER 51 0.0202
125 VIRAL UPPER RESPIRATORY TRACT INFECTION 95 0.0200
126 MENINGITIS BACTERIAL 28 0.0196
127 NEPHRECTOMY 29 0.0195
128 COMPLICATIONS OF TRANSPLANTED KIDNEY 44 0.0194
129 GRAFT VERSUS HOST DISEASE 139 0.0193
130 BK VIRUS INFECTION 65 0.0193
131 VACCINATION FAILURE 32 0.0192
132 BLOOD CREATININE DECREASED 60 0.0191
133 PLATELET COUNT DECREASED 2024 0.0190
134 LABORATORY TEST ABNORMAL 556 0.0188
135 DIALYSIS 263 0.0185
136 WHITE BLOOD CELL DISORDER 49 0.0183
137 VITREOUS DETACHMENT 39 0.0180
138 BLOOD PHOSPHORUS INCREASED 49 0.0179
139 ADENOVIRUS INFECTION 52 0.0179
140 BACTERAEMIA 209 0.0176
141 INFUSION SITE BRUISING 38 0.0176
142 JAUNDICE 468 0.0174
143 BLOOD CREATININE INCREASED 1128 0.0173
144 MUSCLE FATIGUE 73 0.0172
145 PSEUDOMONAL SEPSIS 30 0.0171
146 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1213 0.0170
147 HAEMATOLOGICAL INFECTION 41 0.0167
148 URINARY TRACT INFECTION BACTERIAL 42 0.0166
149 PNEUMONIA KLEBSIELLA 30 0.0163
150 CATHETER SITE INFECTION 61 0.0161
151 VEIN DISORDER 79 0.0158
152 PRE-ECLAMPSIA 75 0.0158
153 RED BLOOD CELL COUNT DECREASED 450 0.0157
154 HAEMODIALYSIS 130 0.0155
155 PORTAL VEIN THROMBOSIS 50 0.0155
156 BLOOD URINE PRESENT 291 0.0153
157 ESCHERICHIA URINARY TRACT INFECTION 64 0.0150
158 BACTERIAL SEPSIS 49 0.0150
159 NEUTROPHIL COUNT ABNORMAL 42 0.0148
160 HAEMOLYTIC ANAEMIA 133 0.0148
161 BLOOD COUNT ABNORMAL 225 0.0148
162 VITREOUS FLOATERS 144 0.0146
163 BLOOD CHLORIDE INCREASED 25 0.0145
164 VIRAL INFECTION 481 0.0144
165 MENINGITIS CRYPTOCOCCAL 25 0.0143
166 DYSPNOEA EXERTIONAL 537 0.0142
167 ESCHERICHIA SEPSIS 41 0.0141
168 BLOOD BILIRUBIN INCREASED 374 0.0138
169 PROTEINURIA 262 0.0138
170 RESPIRATORY TRACT INFECTION VIRAL 32 0.0137
171 BILIRUBIN CONJUGATED INCREASED 32 0.0137
172 BLOOD IRON DECREASED 162 0.0136
173 THROMBOTIC THROMBOCYTOPENIC PURPURA 48 0.0136
174 BLOOD UREA INCREASED 228 0.0136
175 DEVICE RELATED SEPSIS 27 0.0134
176 VARICELLA 32 0.0134
177 LUPUS NEPHRITIS 25 0.0134
178 SLEEP DEFICIT 28 0.0132
179 CYTOMEGALOVIRUS VIRAEMIA 58 0.0130
180 ESCHERICHIA BACTERAEMIA 30 0.0127
181 INFUSION SITE EXTRAVASATION 79 0.0127
182 GLOMERULONEPHRITIS 31 0.0127
183 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 120 0.0126
184 ENDOTRACHEAL INTUBATION 35 0.0125
185 THERAPEUTIC RESPONSE SHORTENED 413 0.0124
186 EXPOSURE DURING PREGNANCY 772 0.0124
187 MONOCYTE COUNT INCREASED 45 0.0124
188 STAPHYLOCOCCAL SEPSIS 61 0.0123
189 SARS-COV-2 TEST POSITIVE 162 0.0123
190 YELLOW SKIN 57 0.0122
191 RHINOVIRUS INFECTION 47 0.0121
192 PSEUDOMONAS INFECTION 103 0.0120
193 ARTHRITIS BACTERIAL 49 0.0119
194 GLOMERULAR FILTRATION RATE DECREASED 146 0.0119
195 ANURIA 102 0.0118
196 IRITIS 36 0.0118
197 WHITE BLOOD CELL COUNT ABNORMAL 75 0.0117
198 ENDOCARDITIS 60 0.0117
199 SYSTEMIC CANDIDA 29 0.0115
200 FIBRIN D DIMER INCREASED 41 0.0115
201 RETINAL HAEMORRHAGE 82 0.0115
202 CYTOMEGALOVIRUS INFECTION 191 0.0115
203 BODY TEMPERATURE INCREASED 234 0.0115
204 IMMUNOSUPPRESSION 101 0.0114
205 DYSPHAGIA 1085 0.0114
206 HYPERVOLAEMIA 56 0.0113
207 BLOOD IMMUNOGLOBULIN G DECREASED 28 0.0113
208 FLANK PAIN 104 0.0111
209 RENAL IMPAIRMENT 926 0.0110
210 BILE DUCT STONE 35 0.0110
211 PRODUCT TEMPERATURE EXCURSION ISSUE 56 0.0109
212 FOOD POISONING 58 0.0108
213 FLUID OVERLOAD 155 0.0106
214 CEREBRAL THROMBOSIS 30 0.0106
215 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
216 PHYSICAL DECONDITIONING 27 0.0105
217 IRIDOCYCLITIS 33 0.0104
218 GASTROENTERITIS 152 0.0104
219 MULTIPLE ORGAN DYSFUNCTION SYNDROME 294 0.0104
220 ASTHENOPIA 57 0.0104
221 PROTEIN URINE PRESENT 51 0.0102
222 UNEVALUABLE EVENT 773 0.0102
223 URINE OUTPUT DECREASED 89 0.0102
224 BONE MARROW FAILURE 205 0.0101
225 BLOOD ALBUMIN DECREASED 80 0.0101
226 MUSCULAR WEAKNESS 1141 0.0100
227 RENAL PAIN 106 0.0100
228 FATIGUE 7706 0.0099
229 FACIAL PARESIS 35 0.0099
230 ESCHERICHIA INFECTION 81 0.0098
231 MUSCLE STRAIN 85 0.0098
232 END STAGE RENAL DISEASE 179 0.0098
233 PYELONEPHRITIS 85 0.0098
234 GASTROENTERITIS VIRAL 177 0.0098
235 THROMBOSIS IN DEVICE 32 0.0098
236 BRAIN DEATH 30 0.0097
237 EXPOSURE DURING BREAST FEEDING 32 0.0097
238 FOETAL GROWTH RESTRICTION 58 0.0095
239 PULMONARY HAEMORRHAGE 74 0.0095
240 PORTAL HYPERTENSION 29 0.0094
241 ANIMAL BITE 25 0.0094
242 SCLERODERMA 34 0.0093
243 INTERNATIONAL NORMALISED RATIO ABNORMAL 32 0.0093
244 HOSPITALISATION 1423 0.0093
245 MYELOFIBROSIS 28 0.0093
246 INSURANCE ISSUE 141 0.0092
247 PNEUMONIA FUNGAL 36 0.0091
248 ARTHRITIS INFECTIVE 42 0.0090
249 SPLENOMEGALY 106 0.0090
250 HAEMOGLOBIN INCREASED 41 0.0090
251 PHOTOPHOBIA 169 0.0090
252 STAPHYLOCOCCAL BACTERAEMIA 39 0.0090
253 HAEMATURIA 304 0.0089
254 UPPER RESPIRATORY TRACT INFECTION 410 0.0089
255 STRABISMUS 26 0.0088
256 AUTOIMMUNE HAEMOLYTIC ANAEMIA 30 0.0087
257 NASOPHARYNGITIS 1607 0.0087
258 PREGNANCY 174 0.0087
259 MATERNAL EXPOSURE DURING BREAST FEEDING 35 0.0086
260 RENAL FUNCTION TEST ABNORMAL 40 0.0086
261 PROTEIN TOTAL DECREASED 32 0.0085
262 PRODUCT PREPARATION ISSUE 55 0.0084
263 OLIGURIA 52 0.0084
264 BLOOD CULTURE POSITIVE 25 0.0083
265 CHOLELITHIASIS 273 0.0083
266 LOW BIRTH WEIGHT BABY 66 0.0083
267 KLEBSIELLA INFECTION 42 0.0083
268 BLOOD DISORDER 66 0.0082
269 EYE INFLAMMATION 78 0.0082
270 RESPIRATORY SYNCYTIAL VIRUS INFECTION 71 0.0081
271 BACTERIAL INFECTION 152 0.0081
272 BLOOD CALCIUM DECREASED 91 0.0081
273 CHOLECYSTITIS 96 0.0081
274 LOWER RESPIRATORY TRACT INFECTION 364 0.0080
275 INFLUENZA 886 0.0079
276 PYREXIA 2745 0.0079
277 INFECTION 1144 0.0079
278 MUSCULOSKELETAL DISCOMFORT 136 0.0079
279 ORGANISING PNEUMONIA 39 0.0079
280 ENTEROCOCCAL INFECTION 38 0.0079
281 SEPSIS 876 0.0078
282 PNEUMONIA BACTERIAL 72 0.0078
283 ACUTE PULMONARY OEDEMA 44 0.0078
284 ASTHENIA 2944 0.0078
285 GASTROINTESTINAL INFECTION 70 0.0078
286 INFUSION SITE SWELLING 49 0.0078
287 NECK PAIN 434 0.0078
288 BACK PAIN 1803 0.0078
289 SLUGGISHNESS 79 0.0077
290 STAPHYLOCOCCAL INFECTION 255 0.0077
291 CYTOMEGALOVIRUS INFECTION REACTIVATION 34 0.0077
292 TONSILLITIS 40 0.0077
293 LYMPHOCYTE COUNT INCREASED 25 0.0077
294 BLOOD TEST ABNORMAL 107 0.0076
295 CONJUNCTIVAL HAEMORRHAGE 29 0.0076
296 ENDOPHTHALMITIS 45 0.0075
297 FULL BLOOD COUNT DECREASED 150 0.0074
298 NEPHROTIC SYNDROME 51 0.0074
299 VITAMIN B12 DEFICIENCY 30 0.0074
300 CYTOPENIA 90 0.0073
301 ASPERGILLUS INFECTION 48 0.0073
302 EXPOSURE VIA BREAST MILK 29 0.0073
303 BLOOD POTASSIUM INCREASED 118 0.0073
304 ABDOMINAL PAIN 1681 0.0072
305 BRONCHOPULMONARY ASPERGILLOSIS 56 0.0072
306 POST PROCEDURAL HAEMORRHAGE 84 0.0072
307 STREPTOCOCCAL INFECTION 40 0.0072
308 CARDIOPULMONARY FAILURE 28 0.0072
309 IMMUNODEFICIENCY 107 0.0072
310 THROMBOSIS 577 0.0072
311 TEMPERATURE INTOLERANCE 74 0.0072
312 PNEUMOCYSTIS JIROVECII PNEUMONIA 72 0.0072
313 PREMATURE DELIVERY 114 0.0072
314 ANAEMIA 1364 0.0071
315 SEPTIC SHOCK 309 0.0071
316 HYPERTENSIVE CRISIS 79 0.0071
317 BLOOD PRESSURE ABNORMAL 140 0.0070
318 AZOTAEMIA 28 0.0070
319 URINARY TRACT INFECTION 1190 0.0070
320 WHEELCHAIR USER 31 0.0070
321 MENINGITIS ASEPTIC 31 0.0069
322 PLATELET COUNT INCREASED 90 0.0069
323 INTESTINAL PERFORATION 77 0.0069
324 PHARYNGITIS 85 0.0068
325 HEADACHE 4261 0.0068
326 GENERAL PHYSICAL CONDITION ABNORMAL 46 0.0068
327 HERPES SIMPLEX 44 0.0068
328 SINUS HEADACHE 40 0.0067
329 UVEITIS 91 0.0067
330 DYSARTHRIA 249 0.0066
331 ARTHROPOD BITE 49 0.0066
332 BLOOD MAGNESIUM DECREASED 57 0.0066
333 CLOSTRIDIUM DIFFICILE INFECTION 144 0.0066
334 LEUKAEMIA 62 0.0066
335 BLOOD CREATINE INCREASED 29 0.0065
336 LOCALISED INFECTION 158 0.0065
337 WHITE BLOOD CELL COUNT DECREASED 705 0.0065
338 INTERNATIONAL NORMALISED RATIO DECREASED 26 0.0064
339 PALLOR 174 0.0064
340 VASCULAR DEVICE INFECTION 29 0.0064
341 WALKING AID USER 42 0.0064
342 CELLULITIS 320 0.0063
343 PETECHIAE 66 0.0063
344 RHINORRHOEA 408 0.0063
345 NEUROLOGICAL SYMPTOM 36 0.0063
346 UTERINE LEIOMYOMA 46 0.0063
347 CONTUSION 602 0.0062
348 OFF LABEL USE 5469 0.0062
349 FOETAL DEATH 32 0.0062
350 DISEASE COMPLICATION 28 0.0061
351 IMMUNE THROMBOCYTOPENIA 28 0.0061
352 OROPHARYNGEAL PAIN 561 0.0061
353 IRON DEFICIENCY 27 0.0060
354 CHOLECYSTITIS ACUTE 34 0.0060
355 BLOOD POTASSIUM DECREASED 180 0.0060
356 INFUSION SITE PAIN 77 0.0060
357 UROSEPSIS 55 0.0060
358 URINE ABNORMALITY 27 0.0059
359 BRAIN FOG 93 0.0059
360 HAND FRACTURE 42 0.0059
361 SKIN ABRASION 28 0.0059
362 IMMUNE SYSTEM DISORDER 78 0.0059
363 LIMB DISCOMFORT 183 0.0059
364 DECREASED IMMUNE RESPONSIVENESS 58 0.0059
365 BLOOD PRESSURE INCREASED 900 0.0059
366 RENAL FAILURE CHRONIC 45 0.0058
367 PERICARDIAL EFFUSION 134 0.0058
368 NEUTROPHIL COUNT DECREASED 234 0.0057
369 THROMBOCYTOPENIA 640 0.0057
370 MENORRHAGIA 112 0.0057
371 WOUND INFECTION 62 0.0057
372 CLOSTRIDIUM DIFFICILE COLITIS 60 0.0057
373 PREMATURE BABY 170 0.0056
374 RESPIRATORY TRACT INFECTION 147 0.0056
375 AUTOIMMUNE DISORDER 55 0.0056
376 CHOKING 110 0.0056
377 SUBCUTANEOUS ABSCESS 27 0.0056
378 POSTOPERATIVE WOUND INFECTION 38 0.0056
379 RENAL TUBULAR NECROSIS 55 0.0056
380 CARDIAC VALVE DISEASE 32 0.0056
381 HEAD DISCOMFORT 99 0.0056
382 DRUG EFFECT LESS THAN EXPECTED 82 0.0055
383 RENAL DISORDER 257 0.0055
384 HYPERTENSION 1160 0.0055
385 HOSPICE CARE 54 0.0055
386 ASCITES 159 0.0054
387 CONDITION AGGRAVATED 1639 0.0054
388 NECROSIS 30 0.0054
389 FAECES SOFT 39 0.0054
390 SPEECH DISORDER 276 0.0053
391 MALAISE 2274 0.0052
392 ERYSIPELAS 26 0.0052
393 OEDEMA 280 0.0052
394 INCORRECT DOSE ADMINISTERED 1178 0.0052
395 HAEMORRHOIDAL HAEMORRHAGE 25 0.0051
396 PERITONITIS 106 0.0051
397 INFUSION RELATED REACTION 338 0.0051
398 LYMPHOCYTE COUNT DECREASED 90 0.0051
399 INTESTINAL ISCHAEMIA 28 0.0051
400 HERPES ZOSTER 292 0.0051
401 NEPHROLITHIASIS 233 0.0051
402 NASAL CONGESTION 297 0.0050
403 PANCYTOPENIA 281 0.0050
404 EYE HAEMORRHAGE 67 0.0050
405 DIVERTICULITIS 139 0.0050
406 KIDNEY INFECTION 98 0.0050
407 PULMONARY ALVEOLAR HAEMORRHAGE 28 0.0050
408 PHARYNGITIS STREPTOCOCCAL 54 0.0050
409 DISSEMINATED INTRAVASCULAR COAGULATION 70 0.0050
410 ILLNESS 512 0.0050
411 EAR PAIN 96 0.0049
412 BLEPHAROSPASM 31 0.0049
413 BREAST MASS 33 0.0049
414 MIGRAINE 468 0.0049
415 PRODUCTIVE COUGH 234 0.0049
416 LIMB INJURY 133 0.0049
417 NEUTROPHIL COUNT INCREASED 50 0.0049
418 NERVE COMPRESSION 45 0.0049
419 INTRACRANIAL PRESSURE INCREASED 27 0.0048
420 MUSCULOSKELETAL STIFFNESS 424 0.0048
421 LUNG INFECTION 75 0.0048
422 DYSPNOEA 2725 0.0048
423 GENERAL SYMPTOM 36 0.0048
424 PULMONARY OEDEMA 215 0.0048
425 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 36 0.0048
426 CANDIDA INFECTION 81 0.0048
427 OSTEOMYELITIS 86 0.0047
428 ACUTE MYELOID LEUKAEMIA 74 0.0047
429 RESPIRATORY DISTRESS 131 0.0047
430 EAR INFECTION 126 0.0047
431 DYSSTASIA 138 0.0047
432 HAEMODYNAMIC INSTABILITY 36 0.0047
433 OCULAR DISCOMFORT 53 0.0047
434 HYPOGAMMAGLOBULINAEMIA 31 0.0047
435 APPENDICITIS 44 0.0047
436 HYPERSOMNIA 135 0.0047
437 DECUBITUS ULCER 38 0.0047
438 OROPHARYNGEAL DISCOMFORT 42 0.0046
439 SPUTUM DISCOLOURED 44 0.0046
440 TOOTH INFECTION 61 0.0046
441 INTRAOCULAR PRESSURE INCREASED 59 0.0046
442 GALLBLADDER DISORDER 82 0.0046
443 PNEUMONIA 1486 0.0046
444 PERIPHERAL SWELLING 706 0.0046
445 HEPATOMEGALY 45 0.0046
446 VISUAL FIELD DEFECT 33 0.0046
447 RENAL FAILURE 606 0.0046
448 BLINDNESS 185 0.0045
449 CHILLS 530 0.0045
450 SCIATICA 72 0.0045
451 WHITE BLOOD CELL COUNT INCREASED 172 0.0045
452 ENCEPHALITIS 31 0.0045
453 SYSTEMIC LUPUS ERYTHEMATOSUS 159 0.0045
454 COUGH 1252 0.0045
455 FRUSTRATION TOLERANCE DECREASED 36 0.0045
456 VISUAL IMPAIRMENT 552 0.0044
457 MUSCLE DISORDER 36 0.0044
458 URINE ODOUR ABNORMAL 26 0.0044
459 PAIN IN EXTREMITY 1301 0.0044
460 COVID-19 PNEUMONIA 52 0.0044
461 PULMONARY CONGESTION 58 0.0044
462 EYE DISORDER 144 0.0044
463 GENERALISED OEDEMA 54 0.0044
464 BRAIN OEDEMA 55 0.0043
465 FULL BLOOD COUNT ABNORMAL 46 0.0043
466 LIGAMENT SPRAIN 43 0.0043
467 BLINDNESS TRANSIENT 32 0.0043
468 BLOOD PRESSURE DECREASED 288 0.0043
469 DYSPHONIA 252 0.0043
470 FLUID RETENTION 218 0.0043
471 MULTI-ORGAN FAILURE 74 0.0043
472 MUSCULOSKELETAL PAIN 224 0.0043
473 SINUSITIS 438 0.0043
474 MUSCLE TIGHTNESS 69 0.0043
475 WOUND 119 0.0043
476 LETHARGY 244 0.0042
477 EMBOLISM 35 0.0042
478 CHOLANGITIS 26 0.0042
479 OPTIC NEURITIS 38 0.0042
480 CYSTITIS 133 0.0042
481 EPISTAXIS 312 0.0042
482 NEURALGIA 101 0.0041
483 LEUKOPENIA 207 0.0041
484 HERNIA 80 0.0041
485 CHEST PAIN 765 0.0041
486 TOOTH ABSCESS 42 0.0041
487 VASCULITIS 48 0.0041
488 SEIZURE 474 0.0041
489 HEPATIC CIRRHOSIS 77 0.0041
490 SEASONAL ALLERGY 58 0.0041
491 TERMINAL STATE 27 0.0040
492 RESPIRATORY FAILURE 294 0.0040
493 MYALGIA 682 0.0040
494 ANAL INCONTINENCE 36 0.0040
495 OVARIAN CYST 40 0.0040
496 CARDIOMYOPATHY 59 0.0040
497 DEATH 3439 0.0040
498 EATING DISORDER 85 0.0040
499 FACIAL PARALYSIS 34 0.0040
500 EYE INFECTION 45 0.0040
501 GENERAL PHYSICAL HEALTH DETERIORATION 461 0.0040
502 THERAPY CHANGE 39 0.0040
503 EOSINOPHIL COUNT INCREASED 33 0.0040
504 CYST 49 0.0039
505 MALNUTRITION 44 0.0039
506 SINUS CONGESTION 53 0.0039
507 FOOT FRACTURE 74 0.0039
508 ABSCESS 62 0.0039
509 INFLUENZA LIKE ILLNESS 318 0.0039
510 VITAMIN D DECREASED 33 0.0039
511 LUNG INFILTRATION 34 0.0038
512 GOUT 69 0.0038
513 ABORTION SPONTANEOUS 153 0.0038
514 FEELING ABNORMAL 913 0.0038
515 FEELING COLD 106 0.0038
516 HEAD INJURY 120 0.0038
517 FURUNCLE 30 0.0038
518 COAGULOPATHY 63 0.0038
519 FUNGAL INFECTION 126 0.0038
520 PLEURAL EFFUSION 230 0.0038
521 MUSCULOSKELETAL CHEST PAIN 58 0.0037
522 CONCUSSION 29 0.0037
523 APHASIA 113 0.0037
524 GINGIVAL BLEEDING 51 0.0037
525 SUBARACHNOID HAEMORRHAGE 38 0.0037
526 OEDEMA PERIPHERAL 454 0.0037
527 GAIT DISTURBANCE 708 0.0037
528 BONE PAIN 216 0.0037
529 ACTIVITIES OF DAILY LIVING IMPAIRED 73 0.0037
530 MACULAR DEGENERATION 44 0.0037
531 BRONCHITIS 272 0.0037
532 MENTAL STATUS CHANGES 102 0.0037
533 COVID-19 643 0.0037
534 MASS 51 0.0036
535 BALANCE DISORDER 315 0.0036
536 CATARACT 217 0.0036
537 CEREBRAL HAEMORRHAGE 130 0.0036
538 RESPIRATORY DISORDER 108 0.0036
539 HYDRONEPHROSIS 27 0.0036
540 GAIT INABILITY 120 0.0036
541 TOOTHACHE 65 0.0036
542 HAEMORRHAGIC STROKE 28 0.0036
543 THERAPY NON-RESPONDER 161 0.0036
544 VOMITING 1683 0.0036
545 POST PROCEDURAL INFECTION 29 0.0036
546 ASPIRATION 39 0.0036
547 POLYURIA 29 0.0035
548 GRIP STRENGTH DECREASED 31 0.0035
549 LACERATION 33 0.0035
550 FEEDING DISORDER 71 0.0035
551 HYPERBILIRUBINAEMIA 36 0.0035
552 ERECTILE DYSFUNCTION 89 0.0035
553 MITRAL VALVE INCOMPETENCE 39 0.0034
554 ELECTROLYTE IMBALANCE 40 0.0034
555 DEPRESSED MOOD 182 0.0034
556 LYMPHOMA 53 0.0034
557 CHEST DISCOMFORT 350 0.0034
558 SPINAL PAIN 40 0.0034
559 INCONTINENCE 36 0.0034
560 ARTHRALGIA 1415 0.0034
561 RENAL CYST 27 0.0034
562 MUSCLE ATROPHY 43 0.0034
563 VISION BLURRED 465 0.0034
564 DEHYDRATION 450 0.0034
565 RETINAL DETACHMENT 31 0.0034
566 IRON DEFICIENCY ANAEMIA 31 0.0034
567 TOOTH FRACTURE 37 0.0034
568 COLON CANCER 50 0.0034
569 HEPATIC FAILURE 101 0.0033
570 CARDIO-RESPIRATORY ARREST 140 0.0033
571 ROAD TRAFFIC ACCIDENT 140 0.0033
572 PELVIC FRACTURE 26 0.0033
573 ACUTE RESPIRATORY DISTRESS SYNDROME 59 0.0033
574 BLINDNESS UNILATERAL 47 0.0033
575 NERVE INJURY 37 0.0033
576 FALL 1105 0.0033
577 DIARRHOEA HAEMORRHAGIC 31 0.0033
578 HEMIPARESIS 56 0.0033
579 DIZZINESS POSTURAL 32 0.0033
580 RESTLESS LEGS SYNDROME 60 0.0033
581 SKIN INFECTION 37 0.0033
582 APHONIA 46 0.0033
583 PULMONARY MASS 49 0.0033
584 MOBILITY DECREASED 236 0.0033
585 CHOLESTASIS 63 0.0033
586 ARTHRITIS 258 0.0033
587 THYROID DISORDER 50 0.0032
588 HAEMATOMA 84 0.0032
589 BLOOD SODIUM DECREASED 61 0.0032
590 CARDIAC MURMUR 28 0.0032
591 NERVOUS SYSTEM DISORDER 101 0.0032
592 JOINT INJURY 69 0.0032
593 SUBDURAL HAEMATOMA 46 0.0032
594 GENERALISED TONIC-CLONIC SEIZURE 53 0.0032
595 INTERVERTEBRAL DISC PROTRUSION 70 0.0032
596 LIVER DISORDER 142 0.0032
597 CARDIAC FAILURE 257 0.0032
598 BLOOD CALCIUM INCREASED 28 0.0032
599 DEEP VEIN THROMBOSIS 207 0.0032
600 MUSCLE SPASMS 581 0.0032
601 DENTAL CARIES 35 0.0032
602 UPPER LIMB FRACTURE 63 0.0032
603 CARDIAC ARREST 261 0.0032
604 SCAR 54 0.0032
605 CHOLECYSTECTOMY 36 0.0031
606 BODY TEMPERATURE DECREASED 31 0.0031
607 PAIN 1934 0.0031
608 DEVICE OCCLUSION 44 0.0031
609 PULMONARY THROMBOSIS 34 0.0031
610 ACCIDENT 37 0.0031
611 SPINAL FRACTURE 62 0.0031
612 CAESAREAN SECTION 36 0.0031
613 DISEASE RECURRENCE 147 0.0031
614 PNEUMONIA ASPIRATION 77 0.0031
615 DEMENTIA 86 0.0031
616 BLOOD PRESSURE SYSTOLIC INCREASED 60 0.0031
617 GROIN PAIN 27 0.0031
618 ACUTE RESPIRATORY FAILURE 59 0.0031
619 PANCREATITIS 162 0.0031
620 MALIGNANT MELANOMA 41 0.0031
621 HAEMOPTYSIS 85 0.0030
622 HICCUPS 25 0.0030
623 SLEEP APNOEA SYNDROME 58 0.0030
624 SECRETION DISCHARGE 38 0.0030
625 FACIAL PAIN 27 0.0030
626 ATRIAL FIBRILLATION 294 0.0030
627 BASAL CELL CARCINOMA 47 0.0030
628 MYOPATHY 26 0.0030
629 HYPOAESTHESIA 447 0.0030
630 SINUS DISORDER 59 0.0030
631 PULMONARY HYPERTENSION 62 0.0030
632 TENDERNESS 31 0.0030
633 HEART RATE IRREGULAR 67 0.0030
634 NAUSEA 2346 0.0030
635 HEART RATE DECREASED 104 0.0030
636 OSTEONECROSIS 97 0.0030
637 BLOOD ALKALINE PHOSPHATASE INCREASED 73 0.0029
638 ABDOMINAL DISTENSION 305 0.0029
639 ORAL HERPES 57 0.0029
640 INTERVERTEBRAL DISC DEGENERATION 27 0.0029
641 SWELLING FACE 190 0.0029
642 BLOOD PRESSURE FLUCTUATION 70 0.0029
643 EYE PAIN 164 0.0029
644 IMPAIRED DRIVING ABILITY 33 0.0029
645 BRAIN INJURY 29 0.0029
646 NEUTROPENIA 392 0.0029
647 POOR QUALITY SLEEP 62 0.0029
648 INCORRECT PRODUCT ADMINISTRATION DURATION 62 0.0029
649 LUNG DISORDER 140 0.0029
650 GLAUCOMA 55 0.0029
651 NIGHT SWEATS 91 0.0028
652 JOINT STIFFNESS 74 0.0028
653 FOETAL EXPOSURE DURING PREGNANCY 229 0.0028
654 NEOPLASM MALIGNANT 188 0.0028
655 PULMONARY EMBOLISM 267 0.0028
656 DEAFNESS 73 0.0028
657 DIZZINESS 1392 0.0028
658 COLD SWEAT 49 0.0028
659 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 501 0.0028
660 ANKLE FRACTURE 43 0.0028
661 HAEMORRHAGE 290 0.0028
662 ABDOMINAL PAIN UPPER 571 0.0028
663 BEDRIDDEN 36 0.0027
664 CONFUSIONAL STATE 442 0.0027
665 PARALYSIS 39 0.0027
666 HYPOTENSION 546 0.0027
667 HAEMORRHOIDS 53 0.0027
668 SWELLING 252 0.0027
669 ABDOMINAL PAIN LOWER 68 0.0027
670 HYPOKINESIA 39 0.0027
671 DIARRHOEA 1730 0.0027
672 PRODUCT PREPARATION ERROR 55 0.0027
673 SNEEZING 60 0.0027
674 OSTEOPOROSIS 110 0.0027
675 HIP FRACTURE 86 0.0027
676 RIB FRACTURE 55 0.0027
677 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 78 0.0027
678 DYSURIA 98 0.0027
679 THERAPEUTIC PRODUCT EFFECT DECREASED 119 0.0027
680 DIABETES MELLITUS 202 0.0026
681 HAEMATEMESIS 67 0.0026
682 EAR DISCOMFORT 27 0.0026
683 ACUTE KIDNEY INJURY 402 0.0026
684 WEIGHT DECREASED 732 0.0026
685 CENTRAL NERVOUS SYSTEM LESION 36 0.0026
686 LIVER FUNCTION TEST INCREASED 56 0.0026
687 ENCEPHALOPATHY 64 0.0026
688 PHOTOSENSITIVITY REACTION 43 0.0026
689 SOMNOLENCE 524 0.0026
690 INJECTION SITE EXTRAVASATION 32 0.0026
691 ATELECTASIS 25 0.0026
692 GASTROINTESTINAL HAEMORRHAGE 214 0.0026
693 VERTIGO 156 0.0026
694 C-REACTIVE PROTEIN INCREASED 93 0.0026
695 JOINT DISLOCATION 27 0.0026
696 ABDOMINAL DISCOMFORT 427 0.0025
697 ILL-DEFINED DISORDER 154 0.0025
698 CARDIOMEGALY 31 0.0025
699 SMALL INTESTINAL OBSTRUCTION 31 0.0025
700 HYPOPHAGIA 64 0.0025
701 DECREASED ACTIVITY 27 0.0025
702 FISTULA 28 0.0025
703 BACK INJURY 27 0.0025
704 SKIN DISCOLOURATION 114 0.0025
705 COLITIS 94 0.0025
706 THROAT TIGHTNESS 67 0.0025
707 LIVER FUNCTION TEST ABNORMAL 72 0.0025
708 MUSCLE TWITCHING 57 0.0025
709 MOUTH ULCERATION 52 0.0025
710 PRESYNCOPE 60 0.0025
711 ISCHAEMIC STROKE 44 0.0025
712 BLOOD GLUCOSE FLUCTUATION 27 0.0025
713 HEPATITIS 63 0.0025
714 MEMORY IMPAIRMENT 338 0.0025
715 BACK DISORDER 40 0.0025
716 PNEUMOTHORAX 39 0.0025
717 GASTROINTESTINAL DISORDER 220 0.0025
718 POST PROCEDURAL COMPLICATION 47 0.0024
719 PANCREATITIS ACUTE 55 0.0024
720 HEART RATE INCREASED 242 0.0024
721 BREAST PAIN 26 0.0024
722 FACE OEDEMA 41 0.0024
723 TRANSIENT ISCHAEMIC ATTACK 82 0.0024
724 URINARY INCONTINENCE 72 0.0024
725 CEREBROVASCULAR ACCIDENT 411 0.0024
726 SKIN CANCER 52 0.0024
727 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 126 0.0024
728 CHRONIC KIDNEY DISEASE 183 0.0024
729 SKIN LESION 66 0.0024
730 BLOOD GLUCOSE ABNORMAL 44 0.0024
731 FEELING HOT 146 0.0024
732 PROCEDURAL PAIN 66 0.0024
733 LEUKOCYTOSIS 43 0.0024
734 INTERNAL HAEMORRHAGE 27 0.0024
735 THERAPEUTIC RESPONSE DECREASED 143 0.0024
736 ASPARTATE AMINOTRANSFERASE INCREASED 125 0.0024
737 VAGINAL HAEMORRHAGE 102 0.0023
738 INTERNATIONAL NORMALISED RATIO INCREASED 67 0.0023
739 DECREASED APPETITE 545 0.0023
740 HAEMORRHAGE INTRACRANIAL 35 0.0023
741 ILEUS 29 0.0023
742 CEREBRAL INFARCTION 57 0.0023
743 OXYGEN SATURATION DECREASED 131 0.0023
744 PERIPHERAL COLDNESS 32 0.0023
745 TOOTH EXTRACTION 29 0.0023
746 RECTAL HAEMORRHAGE 100 0.0023
747 LOSS OF CONSCIOUSNESS 298 0.0023
748 HEPATITIS C 28 0.0023
749 THROAT IRRITATION 104 0.0023
750 LACRIMATION INCREASED 70 0.0023
751 DISCOMFORT 140 0.0023
752 ALOPECIA 447 0.0023
753 WEIGHT INCREASED 508 0.0023
754 TREATMENT NONCOMPLIANCE 124 0.0023
755 HEPATIC ENZYME INCREASED 154 0.0023
756 ROTATOR CUFF SYNDROME 29 0.0023
757 IMPAIRED HEALING 74 0.0023
758 WRIST FRACTURE 27 0.0023
759 PALPITATIONS 263 0.0022
760 POLLAKIURIA 93 0.0022
761 SYNCOPE 222 0.0022
762 FAECES DISCOLOURED 48 0.0022
763 CARPAL TUNNEL SYNDROME 31 0.0022
764 UNRESPONSIVE TO STIMULI 57 0.0022
765 TACHYCARDIA 196 0.0022
766 HEPATIC STEATOSIS 41 0.0022
767 DISORIENTATION 87 0.0022
768 LYMPHOPENIA 31 0.0022
769 CARDIAC DISORDER 205 0.0022
770 EJECTION FRACTION DECREASED 34 0.0022
771 HYPOXIA 77 0.0022
772 EOSINOPHILIA 38 0.0022
773 BLOOD TRIGLYCERIDES INCREASED 38 0.0021
774 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
775 CARDIAC FAILURE CONGESTIVE 171 0.0021
776 ACUTE HEPATIC FAILURE 29 0.0021
777 LYMPHADENOPATHY 75 0.0021
778 INSOMNIA 563 0.0021
779 CONJUNCTIVITIS 39 0.0021
780 TREMOR 342 0.0021
781 PANIC ATTACK 75 0.0021
782 THERAPY PARTIAL RESPONDER 32 0.0020
783 DRUG INEFFECTIVE 2685 0.0020
784 HYPOACUSIS 87 0.0020
785 EYE SWELLING 75 0.0020
786 PHARYNGEAL OEDEMA 31 0.0020
787 RESPIRATORY TRACT CONGESTION 32 0.0020
788 PARAESTHESIA 316 0.0020
789 HYPERSENSITIVITY 371 0.0020
790 COMPLICATION ASSOCIATED WITH DEVICE 29 0.0020
791 COGNITIVE DISORDER 93 0.0020
792 JOINT SWELLING 240 0.0020
793 DELIRIUM 69 0.0020
794 GASTRITIS 52 0.0020
795 ALANINE AMINOTRANSFERASE INCREASED 121 0.0020
796 PERICARDITIS 33 0.0020
797 VISUAL ACUITY REDUCED 65 0.0020
798 ANAPHYLACTIC REACTION 108 0.0020
799 CARDIOGENIC SHOCK 28 0.0019
800 URINARY RETENTION 65 0.0019
801 ANXIETY 552 0.0019
802 BURNING SENSATION 136 0.0019
803 ALTERED STATE OF CONSCIOUSNESS 42 0.0019
804 NEUROPATHY PERIPHERAL 184 0.0019
805 OCULAR HYPERAEMIA 91 0.0019
806 SHOCK 44 0.0019
807 RENAL FAILURE ACUTE 81 0.0019
808 IMPAIRED GASTRIC EMPTYING 26 0.0019
809 FRACTURE 36 0.0019
810 MOVEMENT DISORDER 61 0.0019
811 HYPERHIDROSIS 244 0.0019
812 HIP ARTHROPLASTY 29 0.0019
813 TRANSAMINASES INCREASED 42 0.0019
814 ULCER 30 0.0019
815 MENTAL DISORDER 82 0.0019
816 COMA 89 0.0019
817 SKIN ULCER 48 0.0019
818 SLEEP DISORDER 131 0.0019
819 RETCHING 39 0.0018
820 METASTASES TO LIVER 32 0.0018
821 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 87 0.0018
822 TENDONITIS 28 0.0018
823 INFLAMMATION 93 0.0018
824 HYPOAESTHESIA ORAL 27 0.0018
825 TINNITUS 82 0.0018
826 HAEMATOCHEZIA 98 0.0018
827 AGRANULOCYTOSIS 33 0.0018
828 OBESITY 28 0.0018
829 TOOTH DISORDER 39 0.0018
830 AMNESIA 114 0.0018
831 HYPOKALAEMIA 80 0.0017
832 MENTAL IMPAIRMENT 42 0.0017
833 RASH 749 0.0017
834 CYANOSIS 27 0.0017
835 RASH PRURITIC 93 0.0017
836 BONE DISORDER 31 0.0017
837 INTESTINAL OBSTRUCTION 64 0.0017
838 ACUTE MYOCARDIAL INFARCTION 50 0.0017
839 DEPRESSION 385 0.0017
840 HYPOTHYROIDISM 54 0.0017
841 NERVOUSNESS 88 0.0017
842 THIRST 30 0.0017
843 CRYING 60 0.0016
844 GASTROOESOPHAGEAL REFLUX DISEASE 132 0.0016
845 MELAENA 36 0.0016
846 DISTURBANCE IN ATTENTION 88 0.0016
847 TASTE DISORDER 33 0.0016
848 INCREASED APPETITE 31 0.0016
849 ADVERSE EVENT 149 0.0016
850 HYPERKALAEMIA 56 0.0016
851 MATERNAL EXPOSURE DURING PREGNANCY 142 0.0016
852 PANCREATIC CARCINOMA 46 0.0016
853 RASH GENERALISED 41 0.0016
854 HOT FLUSH 119 0.0016
855 RASH MACULO-PAPULAR 35 0.0016
856 DISABILITY 31 0.0016
857 ORAL PAIN 35 0.0016
858 BLISTER 87 0.0015
859 ABASIA 38 0.0015
860 CONSTIPATION 335 0.0015
861 DISEASE PROGRESSION 181 0.0015
862 HEPATIC FUNCTION ABNORMAL 57 0.0015
863 GASTRIC ULCER 29 0.0015
864 AGEUSIA 38 0.0015
865 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 108 0.0015
866 DRUG LEVEL INCREASED 25 0.0015
867 MUSCULOSKELETAL DISORDER 28 0.0015
868 LOWER LIMB FRACTURE 28 0.0015
869 ARRHYTHMIA 69 0.0015
870 URTICARIA 244 0.0015
871 DYSPEPSIA 142 0.0014
872 LOCAL SWELLING 25 0.0014
873 PRODUCT DOSE OMISSION 93 0.0014
874 PRURITUS 545 0.0014
875 PRODUCT DOSE OMISSION ISSUE 416 0.0014
876 MUCOSAL INFLAMMATION 37 0.0014
877 LUNG NEOPLASM MALIGNANT 58 0.0014
878 BLOOD GLUCOSE INCREASED 264 0.0014
879 FIBROMYALGIA 34 0.0014
880 FEMUR FRACTURE 43 0.0014
881 DRY EYE 69 0.0014
882 BLOOD GLUCOSE DECREASED 66 0.0014
883 PNEUMONITIS 37 0.0014
884 TOOTH LOSS 28 0.0013
885 DEVICE ISSUE 121 0.0013
886 PAIN IN JAW 38 0.0013
887 PRODUCT ADMINISTRATION ERROR 27 0.0013
888 ERYTHEMA 270 0.0013
889 HEPATOTOXICITY 29 0.0013
890 OSTEOARTHRITIS 55 0.0013
891 MYOCARDIAL INFARCTION 226 0.0013
892 SKIN DISORDER 43 0.0013
893 METABOLIC ACIDOSIS 41 0.0013
894 TYPE 2 DIABETES MELLITUS 43 0.0013
895 NO ADVERSE EVENT 230 0.0013
896 FEBRILE NEUTROPENIA 84 0.0013
897 IRRITABLE BOWEL SYNDROME 27 0.0013
898 PRURITUS GENERALISED 27 0.0012
899 ARTHROPATHY 69 0.0012
900 CARDIOVASCULAR DISORDER 31 0.0012
901 SURGERY 71 0.0012
902 INCORRECT DRUG ADMINISTRATION DURATION 34 0.0012
903 HYPERGLYCAEMIA 44 0.0012
904 PLASMA CELL MYELOMA 47 0.0012
905 WHEEZING 70 0.0012
906 RHABDOMYOLYSIS 49 0.0012
907 CONVULSION 67 0.0012
908 IMPAIRED WORK ABILITY 25 0.0012
909 DRUG RESISTANCE 30 0.0012
910 BLOOD CHOLESTEROL INCREASED 54 0.0012
911 STOMATITIS 70 0.0012
912 ANGINA PECTORIS 33 0.0012
913 ADVERSE DRUG REACTION 102 0.0011
914 GAMMA-GLUTAMYLTRANSFERASE INCREASED 25 0.0011
915 RESPIRATORY ARREST 31 0.0011
916 EPILEPSY 34 0.0011
917 DRUG EFFECT INCOMPLETE 40 0.0011
918 SWOLLEN TONGUE 34 0.0011
919 RASH MACULAR 38 0.0011
920 DYSKINESIA 44 0.0011
921 BRADYCARDIA 57 0.0011
922 EMOTIONAL DISORDER 33 0.0011
923 RASH ERYTHEMATOUS 51 0.0011
924 IRRITABILITY 64 0.0011
925 MOOD ALTERED 29 0.0011
926 FLUSHING 107 0.0011
927 BREAST CANCER 98 0.0011
928 ANAPHYLACTIC SHOCK 27 0.0010
929 FREQUENT BOWEL MOVEMENTS 28 0.0010
930 ASTHMA 117 0.0010
931 DEVICE DISLOCATION 45 0.0010
932 GLYCOSYLATED HAEMOGLOBIN INCREASED 26 0.0010
933 CORONARY ARTERY DISEASE 31 0.0010
934 INTERSTITIAL LUNG DISEASE 49 0.0010
935 RENAL INJURY 30 0.0010
936 FEAR 27 0.0010
937 DRUG INTOLERANCE 94 0.0010
938 COLITIS ULCERATIVE 42 0.0009
939 FLATULENCE 53 0.0009
940 LIP SWELLING 31 0.0009
941 PAIN OF SKIN 25 0.0009
942 LACTIC ACIDOSIS 30 0.0009
943 DYSGEUSIA 68 0.0009
944 INJECTION SITE SWELLING 70 0.0009
945 HYPOGLYCAEMIA 42 0.0009
946 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
947 AGITATION 62 0.0008
948 ANGER 28 0.0008
949 EYE IRRITATION 47 0.0008
950 GASTRIC DISORDER 28 0.0008
951 INJURY 57 0.0008
952 DRUG DOSE OMISSION 130 0.0008
953 HALLUCINATION 59 0.0008
954 EYE PRURITUS 26 0.0008
955 PROSTATE CANCER 62 0.0008
956 RESTLESSNESS 28 0.0008
957 ACNE 58 0.0008
958 ECZEMA 40 0.0008
959 RHEUMATOID ARTHRITIS 84 0.0007
960 DRY MOUTH 58 0.0007
961 EXTRA DOSE ADMINISTERED 28 0.0007
962 INTENTIONAL PRODUCT USE ISSUE 60 0.0007
963 THERAPY CESSATION 35 0.0007
964 ABNORMAL BEHAVIOUR 27 0.0007
965 ANGIOEDEMA 29 0.0007
966 DRUG EFFECT DECREASED 34 0.0006
967 THERAPEUTIC RESPONSE UNEXPECTED 28 0.0006
968 SKIN EXFOLIATION 52 0.0006
969 HYPONATRAEMIA 34 0.0006
970 TREATMENT FAILURE 49 0.0006
971 DRY SKIN 77 0.0006
972 DEVICE LEAKAGE 25 0.0006
973 UNDERDOSE 42 0.0006
974 DEVICE MALFUNCTION 36 0.0005
975 THERAPY INTERRUPTED 36 0.0005
976 INJECTION SITE PRURITUS 33 0.0005
977 INJECTION SITE BRUISING 37 0.0005
978 SKIN BURNING SENSATION 32 0.0004
979 INJECTION SITE PAIN 136 0.0004
980 PRODUCT USE IN UNAPPROVED INDICATION 109 0.0004
981 EMOTIONAL DISTRESS 52 0.0004
982 INJECTION SITE REACTION 29 0.0004
983 SUICIDAL IDEATION 36 0.0004
984 MALIGNANT NEOPLASM PROGRESSION 38 0.0004
985 INJECTION SITE ERYTHEMA 43 0.0003
986 INJECTION SITE HAEMORRHAGE 26 0.0003
987 PRODUCT STORAGE ERROR 28 0.0003
988 DRUG INTERACTION 50 0.0003
989 PRODUCT USE ISSUE 50 0.0003
990 OVERDOSE 55 0.0003
991 TOXICITY TO VARIOUS AGENTS 40 0.0002
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 32 0.0002